1-3 of 3
ashap protocol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Primary and Secondary Transformed B-Cell Lymphomas

Sedat Demirdas, Lewin Eisele, MD, Jörg Hense, MD, Ulrich Dührsen, MD, Andreas Hüttmann, MD
Journal: Blood
Blood (2015) 126 (23): 3894.
https://doi.org/10.1182/blood.V126.23.3894.3894
Published: 2015
Journal Articles

Incidence and Risk Factors for Severe Thrombocytopenia in Lymphoma Patients Receiving Chemotherapy.

Auris Huen, PharmD, Xiao Zhou, MD, PhD, Shyam Teegala, M.D., Yuan Ji, PhD, Luis Fayad, M.D., Jorge Enrique Romaguera, M.D., F.B. Hagemeister, M.D., Saroj Vadhan-Raj, M.D.
Journal: Blood
Blood (2006) 108 (11): 3994.
https://doi.org/10.1182/blood.V108.11.3994.3994
Published: 2006
Journal Articles

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

J. Rodriguez, M.A. Rodriguez, L. Fayad, P. McLaughlin, F. Swan, A. Sarris, J. Romaguera, B. Andersson, F. Cabanillas, F.B. Hagemeister
Journal: Blood
Blood (1999) 93 (11): 3632–3636.
https://doi.org/10.1182/blood.V93.11.3632
Published: 1999